First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...
The Ministry of Public Health (MSP) highlighted its ongoing efforts to prevent, control, and eliminate tropical diseases such ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...
The General Directorate of Epidemiology reported low incidences of dengue, cholera, and leptospirosis, as can be seen in ...
Deadly viruses could become endemic in Europe unless urgent measures are taken, a leading expert has warned. Rising global ...
Spring and warmer months happen to be their favorite season when worker ants come out of their underground hibernation, and ...
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
Chikungunya infections began to increase by the end of September 2022 in Paraguay, which declared on Feb. 24 that it was on alert due to the “atypical clinical and epidemiological behavior” of ...
Summer brings warmer temperatures and longer days, and of course that means spending more time outdoors. Unfortunately, it ...
Here’s a look at Zika virus, an illness spread through mosquito bites that can cause birth defects and other neurological defects. Facts Sources: Centers for Disease Control and Prevention (CDC), ...
The Centers for Disease Control and Prevention estimates that in 2022, around 608,000 people died from malaria, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results